» Articles » PMID: 37943609

Gut Microbiota and Tumor-associated Macrophages: Potential in Tumor Diagnosis and Treatment

Overview
Journal Gut Microbes
Date 2023 Nov 9
PMID 37943609
Authors
Affiliations
Soon will be listed here.
Abstract

Avoiding immune destruction and polymorphic microbiomes are two key hallmarks of cancer. The tumor microenvironment (TME) is essential for the development of solid tumors, and the function of tumor-associated macrophages (TAMs) in the TME is closely linked to tumor prognosis. Therefore, research on TAMs could improve the progression and control of certain tumor patients. Additionally, the intestinal flora plays a crucial role in metabolizing substances and maintaining a symbiotic relationship with the host through a complex network of interactions. Recent experimental and clinical studies have suggested a potential link between gut microbiome and TME, particularly in regulating TAMs. Understanding this association could improve the efficacy of tumor immunotherapy. This review highlights the regulatory role of intestinal flora on TAMs, with a focus on gut microbiota and their metabolites. The implications of this association for tumor diagnosis and treatment are also discussed, providing a promising avenue for future clinical treatment strategies.

Citing Articles

Probiotic-Derived Metabolites from OC01 Reprogram Tumor-Associated Macrophages to an Inflammatory Anti-Tumoral Phenotype: Impact on Colorectal Cancer Cell Proliferation and Migration.

Garavaglia B, Vallino L, Ferraresi A, Amoruso A, Pane M, Isidoro C Biomedicines. 2025; 13(2).

PMID: 40002754 PMC: 11853712. DOI: 10.3390/biomedicines13020339.


From silent partners to potential therapeutic targets: macrophages in colorectal cancer.

Khizar H, Ali K, Wang J Cancer Immunol Immunother. 2025; 74(4):121.

PMID: 39998578 PMC: 11861851. DOI: 10.1007/s00262-025-03965-w.


Platycodon grandiflorum-derived extracellular vesicles suppress triple-negative breast cancer growth by reversing the immunosuppressive tumor microenvironment and modulating the gut microbiota.

Yang M, Guo J, Li J, Wang S, Sun Y, Liu Y J Nanobiotechnology. 2025; 23(1):92.

PMID: 39920791 PMC: 11804104. DOI: 10.1186/s12951-025-03139-x.


Chronic Gastrointestinal Disorders and miRNA-Associated Disease: An Up-to-Date.

Giammona A, Galuzzi B, Imperia E, Gervasoni C, Remedia S, Restaneo L Int J Mol Sci. 2025; 26(1.

PMID: 39796266 PMC: 11720538. DOI: 10.3390/ijms26010413.


Advances in Molecular Mechanisms and Therapeutic Strategies in Colorectal Cancer: A New Era of Precision Medicine.

Delle Cave D Int J Mol Sci. 2025; 26(1.

PMID: 39796202 PMC: 11719900. DOI: 10.3390/ijms26010346.


References
1.
Li X, Qi M, He K, Liu H, Yan W, Zhao L . Neospora caninum inhibits tumor development by activating the immune response and destroying tumor cells in a B16F10 melanoma model. Parasit Vectors. 2022; 15(1):332. PMC: 9503190. DOI: 10.1186/s13071-022-05456-8. View

2.
Chu C, Wang S, Li C, Chen S, Hu C, Chung Y . Neurons and astroglia govern microglial endotoxin tolerance through macrophage colony-stimulating factor receptor-mediated ERK1/2 signals. Brain Behav Immun. 2016; 55:260-272. PMC: 4899166. DOI: 10.1016/j.bbi.2016.04.015. View

3.
Rohm T, Fuchs R, Muller R, Keller L, Baumann Z, Bosch A . Obesity in Humans Is Characterized by Gut Inflammation as Shown by Pro-Inflammatory Intestinal Macrophage Accumulation. Front Immunol. 2021; 12:668654. PMC: 8158297. DOI: 10.3389/fimmu.2021.668654. View

4.
Liu Y, Xu J, Ren X, Zhang Y, Ke Z, Zhou J . Cholecystectomy-induced secondary bile acids accumulation ameliorates colitis through inhibiting monocyte/macrophage recruitment. Gut Microbes. 2022; 14(1):2107387. PMC: 9450905. DOI: 10.1080/19490976.2022.2107387. View

5.
Han G, Kim S, Ko W, Lee D, Han I, Sheen S . Transplantation of tauroursodeoxycholic acid-inducing M2-phenotype macrophages promotes an anti-neuroinflammatory effect and functional recovery after spinal cord injury in rats. Cell Prolif. 2021; 54(6):e13050. PMC: 8168422. DOI: 10.1111/cpr.13050. View